ArticleInternational journal of molecular sciences2026

Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword.

Irem Dogan Turacli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.